SCHEMBL7707050

SCHEMBL7707050

Cc1cccc(NC2(C(N)=O)CCN(Cc3ccccc3)CC2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
CYP2D6 P10635 1/20 0.61
KDM4E B2RXH2 3/20 0.57
MAPT P10636 1/20 0.57
RAB9A P51151 1/20 0.57
DCUN1D1 Q96GG9 1/20 0.54
NPFFR1 Q9GZQ6 5/20 0.54
NPFFR2 Q9Y5X5 5/20 0.54
OPRK1 P41145 2/20 0.54
OPRM1 P35372 1/20 0.54
OPRD1 P41143 1/20 0.54
FAAH O00519 1/20 0.53
CHRM2 P08172 1/20 0.51
CHRM3 P20309 1/20 0.51
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA4 P22748 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7830278 0.91 ALDH1A1 (0.63) ALDH1A1CYP2D6KDM4EMAPTRAB9A
SCHEMBL2996293 0.88 CYP2D6 (0.68) ALDH1A1CYP2D6KDM4EMAPTNPFFR1
SCHEMBL3939085 0.87 CYP2D6 (0.65) ALDH1A1CYP2D6NPFFR1NPFFR2OPRK1
SCHEMBL20187124 0.86 ALDH1A1 (0.58) ALDH1A1CYP2D6KDM4ENPFFR1NPFFR2
SCHEMBL20187134 0.86 CYP2D6 (0.58) ALDH1A1CYP2D6NPFFR1NPFFR2OPRK1
SCHEMBL7831915 0.86 ALDH1A1 (0.54) ALDH1A1CYP2D6KDM4EMAPTRAB9A
SCHEMBL11564966 0.86 NPFFR1 (0.64) ALDH1A1CYP2D6KDM4EMAPTRAB9A
SCHEMBL16876743 0.84 CYP2D6 (0.57) ALDH1A1CYP2D6KDM4EMAPTNPFFR1
SCHEMBL11566812 0.84 UBE2M (0.57) ALDH1A1CYP2D6KDM4EMAPTDCUN1D1
SCHEMBL16876740 0.83 CYP2D6 (0.60) ALDH1A1CYP2D6NPFFR1NPFFR2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921125-B1 1,3,8-Triazaspiro[4,5]decan-4-on derivatives HOFFMANN LA ROCHE (CH) 2002-01-30 EP disclosed
EP-1087770-A4 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO INC (US) 2001-11-14 EP disclosed
EP-0944388-A4 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO INC (US) 2001-08-16 EP disclosed
US-6248756-B1 Inhibitors of farnesyl-protein transferase MERCK & CO., INC. 2001-06-19 US disclosed
EP-1087770-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 2001-04-04 EP disclosed
US-6172076-B1 HETEROCYCLE-SUBSTITUTED 1,3,8-TRIAZASPIRO(4,5)DECANE DERIVATIVES; TREATING ARTERIOSCLEROSIS MERCK & CO., INC. 2001-01-09 US disclosed
US-6043366-A USEFUL IN TREATING DISORDERS INVOLVING THE ORPHANIN FQ(A SEVENTEEN AMINO ACID LONG PEPTIDE) RECEPTOR. HOFFMAN-LA ROCHE INC. (US) 2000-03-28 US disclosed
WO-1999065494-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1999-12-23 WO disclosed
EP-0944388-A2 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 1999-09-29 EP disclosed
EP-0921125-A1 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed
US-5891889-A Inhibitors of farnesyl-protein transferase MERCK & CO., INC. (US) 1999-04-06 US disclosed
WO-1997038665-A2 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1997-10-23 WO disclosed